PPMD was joined by Sarepta Therapeutics for a webinar on October 13, 2021 for an update on the company’s EMBARK clinical trial (SRP-9001-301). Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 29:09 PTC Therapeutics — EMFLAZA® Landscape in 2024 9 months ago Care Webinars,Webinars emflaza,ptc therapeutics 53:59 Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD 10 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:00:58 Navigating Steroid Choices: Understanding the Process, Pathways, and Policies 10 months ago Care Webinars,Webinars steroids 1:03:41 Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003 12 months ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 59:54 Overview of Topline Results from Phase 3 EMBARK Study 1 year ago Research & Clinical Trial Webinars,Webinars sarepta 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings 1 year ago Care Webinars,Webinars feature,insurance,medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 1 year ago Research & Clinical Trial Webinars,Webinars capricor 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 1 year ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise «12345…25»Page 3 of 25
by: Parent Project Muscular Dystrophy
